Fortification of chocolate with microencapsulated garlic extract and consumption effects of the product on blood pressure, serum lipid profile, inflammatory and oxidative stress indices in patients with hypertensio
Not Applicable
Recruiting
- Conditions
- Hypertension.Essential (primary) hypertension
- Registration Number
- IRCT20150201020891N2
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Systolic blood pressure >= 130 mmHg or Diastolic blood pressure >= 80 mmHg OR both
Shiraz residence
Participation willingness
Exclusion Criteria
Being in pregnancy or lactation periods
Affected with diabetes or thyroid disorders
Anticoagulant drug consumption
Dietary supplementation of any type
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hypertension. Timepoint: The beginning of the study and the end of the sixth, ninth and fifth weeks. Method of measurement: Digital barometer.;Serum lipid levels. Timepoint: The beginning of the study and the end of the sixth, ninth and fifth weeks. Method of measurement: ELISA kits.;Serum hsCRP level. Timepoint: The beginning of the study and the end of the sixth, ninth and fifth weeks. Method of measurement: RIA kit.;Serum malondealdehyde levels. Timepoint: The beginning of the study and the end of the sixth, ninth and fifth weeks. Method of measurement: Spectrophotometry.
- Secondary Outcome Measures
Name Time Method